Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion

OBJECTIVE: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials. FGF23 has been implicated in several chronic pulmonary diseases. We aimed to determine the association betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Anthony J, Imani, Jewel, Shrestha, Shikshya, Bagwe, Shefali, Lamattina, Anthony M, Vivero, Marina, Goldberg, Hilary J, Rosas, Ivan O, Henske, Elizabeth P, El-Chemaly, Souheil Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171272/
https://www.ncbi.nlm.nih.gov/pubmed/37132737
http://dx.doi.org/10.36416/1806-3756/e20220356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171272/
https://www.ncbi.nlm.nih.gov/pubmed/37132737
http://dx.doi.org/10.36416/1806-3756/e20220356

Ejemplares similares